Recognition of depression

Area of Science:

• Palliative Care
• Psychiatry
• Gerontology

Background:

• Depression is often overlooked in terminally ill patients, frequently misconstrued as an unavoidable aspect of their condition.
• Systematic examination of depression in this vulnerable population remains limited, hindering effective assessment and intervention.

Purpose of the Study:

• To develop and validate a novel instrument, the Mood Evaluation Questionnaire (MEQ), specifically designed to measure depression in terminally ill individuals.
• To establish the reliability and validity of the MEQ by comparing its results with a well-established depression scale.

Main Methods:

• The Mood Evaluation Questionnaire (MEQ) was administered to 27 hospice patients.
• Concurrent assessments included the Geriatric Depression Scale (GDS), Modified Karnofsky Performance Status (MKPS), and a somatic complaints index.
• Statistical analysis focused on the correlation between MEQ scores and other measures.

Main Results:

• The MEQ demonstrated a high correlation with the Geriatric Depression Scale (GDS), indicating strong concurrent validity (p < .01).
• No significant correlation was found between depression levels (as measured by MEQ and GDS) and the Modified Karnofsky score or the number of somatic complaints.
• These findings suggest that depression in terminally ill patients is not solely explained by functional status or physical symptoms.

Conclusions:

• The Mood Evaluation Questionnaire (MEQ) is a reliable and effective instrument for assessing depression in terminally ill patients.
• The MEQ facilitates a more accurate understanding of depression incidence and severity in palliative care settings.
• Further research utilizing the MEQ can enhance the systematic examination of depression in end-of-life care.